EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.
Haghiralsadat F, Amoabediny G, Naderinezhad S, Nazmi K, De Boer JP, Zandieh-Doulabi B, Forouzanfar T, Helder MN.
Haghiralsadat F, et al. Among authors: forouzanfar t.
Pharm Res. 2017 Dec;34(12):2891-2900. doi: 10.1007/s11095-017-2272-6. Epub 2017 Nov 6.
Pharm Res. 2017.
PMID: 29110283